Clarivate Plc (CLVT)
Market Cap | 4.74B |
Revenue (ttm) | 2.63B |
Net Income (ttm) | -986.60M |
Shares Out | 666.29M |
EPS (ttm) | -1.47 |
PE Ratio | n/a |
Forward PE | 9.44 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 4,411,510 |
Open | 7.09 |
Previous Close | 7.00 |
Day's Range | 7.00 - 7.24 |
52-Week Range | 6.07 - 10.03 |
Beta | 1.24 |
Analysts | Hold |
Price Target | 7.94 (+11.52%) |
Earnings Date | May 8, 2024 |
About CLVT
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academi... [Read more]
Financial Performance
In 2023, Clarivate's revenue was $2.63 billion, a decrease of -1.17% compared to the previous year's $2.66 billion. Losses were -$986.60 million, -75.55% less than in 2022.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for CLVT stock is "Hold." The 12-month stock price forecast is $7.94, which is an increase of 11.52% from the latest price.
News
Clarivate joins United Nations SDG Publishers Compact
LONDON , April 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed the United Nations Sustainable Development Go...
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain an...
Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets
New solution offers comprehensive tracking and analysis of market share and size in Brazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON , April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLV...
Clarivate to Report First Quarter 2024 Results on May 8, 2024
LONDON , April 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter...
Clarivate Leadership Presents at Recent Investor Conferences
--- Clarivate CFO and Segment Presidents Discuss Growth Initiatives Including Generative AI Strategies --- LONDON , April 1, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider ...
Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients
Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI LONDON , March 21, 2024 /PRNewswire/ -- Clariv...
New Webinar: Clarivate in the Age of AI - Driving Innovation in Intellectual Property Management and Decision Making
--- Gordon Samson, President, Intellectual Property, Provides a Virtual Update on Strategy and Generative AI Initiatives --- LONDON , March 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leadi...
New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow
--- Henry Levy, President, Life Sciences & Healthcare, Provides a Virtual Update on Strategy and Generative AI Initiatives --- LONDON , March 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a lea...
Clarivate to Present at the BofA Securities 2024 Information & Business Services Conference on March 14
LONDON , March 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief F...
New Webinar: Clarivate in the Age of AI - Innovation Rooted in Academia
--- Bar Veinstein, President, Academia & Government, Provides a Virtual Update on Strategy and Generative AI Initiatives --- LONDON , March 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leadin...
Clarivate Reveals Top 100 Global Innovators 2024
New report introduces rankings for the first time; Samsung Electronics leads the list LONDON , March 5, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative int...
Clarivate and Exor sign agreement
Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors
Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors
Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company's Management and Board, and announces it now has a 10.1% shareholding in the Company and can in...
Clarivate Reports Fourth Quarter and Full Year 2023 Results
— Provides 2024 Outlook — LONDON , Feb. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported res...
Clarivate Recognized in the WTR 1000 2024 for Trademark Business
Highly recommended in trademark management, searching and watching, renewals and recordals LONDON , Feb. 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformativ...
Clarivate Launches New Center for Intellectual Property and Innovation Research
Bringing together expertise, operational practice knowledge and powerful data models to improve innovation and IP decision-making LONDON , Feb. 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a l...
Clarivate Partners with the Financial Times to Power its Business School Rankings
LONDON , Feb. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global provider of transformative intelligence, has partnered with the Financial Times (FT) for the sixth consecutive year to provid...
Clarivate Completes Refinancing of Term Loan and Revolver Extension
LONDON , Feb. 1, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform thei...
Clarivate Launches Web of Science Grants Index to Help Researchers Optimize Funding Strategies
New solution integrates curated data from Pivot-RP to the Web of Science and offers a n expanded view of the funding landscape LONDON , Jan. 29, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a gl...
Clarivate to Report Fourth Quarter and Full Year 2023 Results on February 27, 2024
LONDON , Jan. 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today it wi...
Clarivate Announces Commencement of Term Loan Refinancing Transaction
LONDON , Jan. 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform the...
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Therapeutic advancements for sickle cell disease, RSV, breast cancer, Crohn's and other ailments poised to advance patient health despite urgent challenges facing life science companies LONDON , Jan. ...
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market LONDON ,...
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials LONDON , Dec. 5, 2023 /PRNewswire/...
Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List
Concentration of top talent with 10 countries/regions representing over 80% of list LONDON , Nov. 15, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizat...